Tag Archives: Healthcare

HD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research Reached Agreement for Drug R&D Collaboration

HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.

“We are delighted to enter this partnership. The collaboration will leverage HDB’s extensive capabilities in preclinical drug discovery and development, and create long term potentials for the company.” stated Xuehai Tan, Ph.D., President & CEO of HDB. “In combination of CIBR’s expertise in drug development, we are confident to deliver novel drug candidates over the next few years, and to make this partnership a success.”

“Working with HDB gives CIBR a unique opportunity to showcase its strength in innovative drug discovery and development,” said Wuyi Meng, Ph.D., President of CIBR. “This partnership further demonstrates CIBR’s commitment in the betterment of patient’s lives by bringing forward novel medicines. We will collaborate closely with HDB to accelerate the progress of our collaborative programs”

About HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. is a Shanghai-based, biology-focused preclinical drug discovery contract research organization (CRO). The company offers comprehensive service platforms around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, as well as other research and development services. The company currently collaborates with eight of the ten largest pharmaceutical companies in the world and has established strategic partnerships on many key R&D areas with impacts to their portfolios. The strong scientific expertise, high quality and consistency in deliveries, constantly meeting or exceeding expectations, has earned the company a great reputation in the industry, and helped the company to build its widely recognized leadership in preclinical contract research services.http://www.hdbiosciences.com

About E. J. Corey Institute of Biomedical Research
Located in the Jiangyin High-tech Industry Development Zone in Jiangyin, Jiangsu, E. J. Corey Institute of Biomedical Research (CIBR) is a non-profit research organization founded by Nobel laureate Prof. E. J. Corey with the support from Jiangyin and Jiangsu government. CIBR is committed to scientific research in the broad biomedical field and to the development of novel therapeutics to meet the unmet medical needs of patients. In addition to its strong internal research and discovery capabilities in biomedical research and drug discovery, CIBR has established solid external capabilities in translational medicine and molecular toxicology to support drug development. Under the guidance of Nobel laureate Prof. Corey, CIBR is well poised to contribute to the discovery and development of novel medicines. http://www.cibrnobel.org

Contact Details:
HD Biosciences
Ms. Jessie Yang
Email: yangxiaojie@hdbiosciences.com

CIBR
Dr. Jiaquan Wu;
Email: jwu@cibrnobel.org

 

Via EPR Network
More Healthcare press releases

EMS Healthcare receives ISO accreditation for fourth consecutive year

EMS Healthcare has announced that it has achieved ISO accreditation for the fourth consecutive year.

It is the latest in a long line of endorsements that the UK event marketing organisation has achieved continuously and maintained over the years. It marks EMS Healthcare as a first-class employer.

By investing in standards of best practice, EMS Healthcare not only gives their customers peace of mind and the confidence to do business with them, but they are also able to recruit the best and brightest talent in the event trailer hire and mobile medical accommodation industry.

Ultimately, it strengthens our proposition to both existing clients and prospects; whilst also helping to strengthen their ongoing recruitment drive. Ultimately it makes good business sense all round.

David Legg, Finance Director at EMS said: “We may be a SME business, but we are perfectly formed and certainly have big company values.

“When it comes to our staff, this is no exception, and we’re delighted to have recently passed the BS OHSAS 18001:2007 – Occupational Health and Safety Standard, which is no mean feat.

“It’s the fourth consecutive year that we have achieved the accreditation. And we were among one of the first live events companies to lead the way in its attainment.”

Find out more about EMS Healthcare and mobile medical accomodation today by calling 0151 350 1500 or visiting http://ems-healthcare.com.

Via EPR Network
More Healthcare press releases

BlueFire Marketing Announces Launch of New Healthcare Reminder Service

BlueFire Marketing, a fully integrated marketing firm, announced today the launch of a text message marketing reminder service for healthcare providers. This service allows them to automatically remind patients of upcoming appointments. This reduces time and cost for healthcare providers who manually and individually call patients to remind them of their appointments.

BlueFire Marketing recognizes changing trends in both the market and in consumer preferences. In the U.S., smartphone penetration has reached 54%, and is projected to hit 84% by 2016. This creates an opportunity to reach individuals and build 1-on-1 relationships at an incredibly low cost.

Curt Johnson, President of BlueFire Marketing, said, “The beauty of the smartphone era for retailers and healthcare professionals is that the cost of the marketing medium is paid for by the consumer. The more your marketing mix shifts towards digital, the lower your cost per thousand.”

Via EPR Network
More Healthcare press releases

Innovative Drug Discovery Business, Biosortia Pharmaceuticals, Lands Two Health Care Veterans

Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.

Dieck has spent nearly 30 years in healthcare, including 18 years at Arthur Andersen as a global equity partner and then 10 years with Cardinal Health, a Fortune 20 public company, as a senior executive; there he worked with a broad spectrum of partners, including brand pharmaceutical manufacturers, throughout the supply chain. Dr. Guy Carter has over 30 years of experience working in pharmaceutical R&D, primarily in the discovery and development of microbial natural products. He previously was the leader of natural products drug discovery at Wyeth Research, as head of the Chemical Technologies Department.

“Kurt and Guy make a great team. Their complementary Pharma experiences and backgrounds create great opportunities to accelerate Biosortia’s objective to become the premier, aquatic natural products company with a primary focus in drug discovery,” says Ross Youngs, Biosortia’s Founder and Chairman. “Kurt and Guy bring a wealth of research and business experience along with deep industry relationships in building successful Pharma partnerships. Everyone involved with this young biotech is excited about the future.”

Industry observers have commented that late-stage R&D pipelines are not providing Pharma with the desired revenue growth the market is expecting. Therefore, large Pharma is evolving the way it performs R&D in order to optimize efficiency and to boost patent cliff defenses. These changes require shifting from relying solely on in-house chemistry-based R&D to acquiring and licensing external technologies and natural products based compounds in various stages of development. Biosortia’s ability to supply novel, highly active and potent compounds with drug-like characteristics will increase the productivity and success rate for Pharma as well as reduce the overall cost of the discovery process. The cost to discover, develop and launch a new drug is estimated to reach nearly $3B per drug by 2015. Biosortia’s business model is designed specifically to support Pharma’s needs.

“With nearly unlimited microorganisms (3.7 nonillion), the aquatic environment and its consortia represent an extraordinary opportunity…a new frontier, to access extremely potent and chemically diverse secondary metabolites with drug-like properties with unique mechanisms of action never researched before,” said Dieck. In describing the opportunity, Dieck goes on to say, “Biosortia is on the cutting edge of natural product discovery
and has the capabilities to deliver on its aspiration. Our powerful natural products research team, led by Dr. Guy Carter, in partnership with NOAA’s Dr. Peter Moeller, a leader in aquatic natural products research, has the experience and know-how to decipher the complex unexplored environment in a very efficient manner leveraging all the current state of the art instrumentation. The need for more efficient and effective approaches to drug discovery has never been more important. Biosortia’s innovative technologies, deep research skills and key relationships will efficiently provide thousands of unique natural products as candidates for drug discovery at a time when Pharma is in critical need for “high quality shots on goal.”

“Aquatic microbial consortia are a rich source of metabolically active organisms including microalgae, bacteria, fungi and their secondary metabolites,” states Carter. “Owing to the competitive nature of their habitat, chemical investigations of microbial consortia reveal unique structurally diversified natural products that are responsible for signaling and self-defense that have potential as therapeutics with novel mechanisms of action. Since they have been pre-optimized by nature, these compounds are typically closer to a drug candidate than a synthetic lead, thus requiring less optimization and shorter time when found as ‘hits’ in screening programs.”

The team has also focused on agreements with strategic collaboration partners as vital components to the strategy. Biosortia has recently entered into several collaboration agreements with NOAA, Analyticon and exclusive harvesting relationships, just to name a few. Several others will be advanced by the end of January. Biosortia’s cooperative research and development agreement (CRADA) with NOAA’s Center for Human Health Risk at Hollings Marine Laboratory provides a 5-year framework for research and development regarding the analysis and purification of novel bioactive compounds. According to NOAA’s Technology Partnerships Office, “Success will result in the commercial development of new and unique chemical compounds from the sea which have benefits to human health, either through disease prevention or new treatments for disease.”

Dr. Peter Moeller, NOAA’s Research Scientist who leads the Toxins Natural Products Program stated after analyzing fractions of Biosortia’s biomass, “Coupling NOAA’s mission of characterizing toxins affecting environmental and/or human health with Biosortia’s drug discovery focus turns one man’s toxin into another’s chemotherapeutic. The microorganisms analyzed in the Biosortia biomass identified more unique activity than I have seen in my 30 year career. The volumes achieved from a single harvest delivered an equivalent of 30 years of accumulation. This could materially change the landscape for natural products drug discovery research.”

As of December 31, 2012, Biosortia has identified more than 30 bioactive candidate compounds (hits) from a fresh water eutrophic lake consortium. Therapeutic areas of focus include treatments for cancer, infectious diseases, inflammation and neurological disorders. In addition, more than a dozen of its patent protected compounds are in initial evaluation stage within Eli Lilly’s Open Innovation Drug Discovery Program.

Dieck states, “Looking forward, it is with great optimism. We have a great team built around mutual respect, deep experience, and a desire to succeed and make a difference. We are aligning with the right partners and collaborators to execute our strategy with speed and discipline to provide Pharma with much high quality & diverse compounds vs. “me-too” drugs than they have had in the past 10 years. We are excited about what this company can accomplish, not only for its shareholders but also for the millions of people who have been diagnosed with various forms of chronic diseases who are looking for Pharma to identify better ways to help them extend their lives or live a more productive life. Biosortia can play a big role in identifying compounds that can help Pharma achieve these goals. I am looking forward to the challenge and opportunity to build an industry leading drug discovery company.”

Via EPR Network
More Healthcare press releases

1 800-GET-THIN Says New “Whistle Blower” Lawsuit A Fantasy And Sham

1 800 GET THIN has called a lawsuit filed against it a fantasy and lacking in credibility. The lawsuit, Meyle v. 1 800 GET THIN, was filed in LA Superior Court (BC486169) on Thursday, and charges that San Diego Ambulatory Surgery Center failed to properly sterilize its instruments on December 30 and 31 of 2011. However, Konrad Trope, the attorney for the surgery enter, said that Jessica Meyle, the plaintiff, sent an email on January 5, 2012 which acknowledged the instruments were, in fact, properly sterilized. The email from Jessica Meyle said: “…it [the sterilizer] passed!!!!:):):) Mejid is looking at the autoclave now. He says the problem may have been that we removed the Bowie Dicks too quickly. He recommends to crack the door & leave the tests in the autoclave for 20 minutes. Thank you, Jessica”.

Trope stated “this email conclusively proves that the plaintiffs filed a false claim with the court knowing full well that the sterilizer worked.” Trope added that “it is improper that the plaintiffs’ attorneys Alexander Robertson and John Walker filed this lawsuit without doing an appropriate investigation of this false allegation as required by law.”

Trope further stated that “the plaintiffs and their attorneys are looking for a fast buck with false allegations.”

1 800 GET THIN is a marketing firm and does not perform medical procedures. The plaintiffs’ attorneys Robertson and Walker recently dismissed 1 800 GET THIN from their prior “whistleblower” lawsuit. 1 800 GET THIN will challenge this lawsuit as well. Trope added that “the plaintiffs and their attorneys have gone ahead and filed false claims which will inevitably result in their suit being dismissed with the strong likelihood that they will face a lawsuit for malicious prosecution.”

Trope has challenged the plaintiffs to explain the contradiction between their claims, the emails, and the written records. The record of quality medical care and safety in San Diego Ambulatory Surgery Center is excellent.

Trope says he is deeply concerned about Jessica Meyle’s criminal history and credibility. “She has a conviction for Retail Theft in Pennsylvania in the case of Commonwealth v. Jessica Gordon (her maiden name), in case number CP-23-CR-0007812-2006.”

Contact Details: Contact: Konrad Trope (888) 942-9997
Centurion Law Group

Via EPR Network
More Healthcare press releases

Varicose Vein Treatment Offers Multi-Million Savings For Hard-Pressed NHS

As the pressure on the NHS to find efficiency savings increases, several trusts are looking to adopt a pioneering approach to varicose vein treatment that saves resources, while improving patient outcomes.

If adopted by all hospitals, The VNUS Closure procedure for the treatment of varicose veins, endorsed by the NHS National Innovation Centre, could save the health service around £17million.

The major benefits for the NHS lie in the fact that this procedure is much less resource-intensive than surgery. Conventional varicose vein stripping is a common operation, and one that takes up a great deal of operating theatre time.

The VNUS Closure procedure, however, can be carried-out in a treatment room, freeing up surgical theatres, enabling the NHS to treat other serious conditions more quickly and so reduce waiting-times.

It is said that as many as one in three adults in the UK suffers from venous reflux or varicose veins at some point in their life, and varicose vein treatment is one of the most common hospital procedures.

Almost 90,000 varicose vein operations were carried-out by the NHS in 2005-06, while approximately 20,000 similar operations were conducted privately, producing a total of around 110,000 procedures per year.

As long ago as 1999, a study conducted by the University of Edinburgh, put the total cost to the NHS at between £400m and £600m.

It is difficult to compare accurately the direct costs of conventional surgery and VNUS Closure. However, as the procedure is carried out under local anaesthetic without an overnight stay, and performed with minimal staff in a simple treatment room, this technique offers significant benefits for the NHS.

Cost savings are estimated to be between £40 and £450 per patient, depending on whether or not the patient requires an overnight stay.

The VNUS Closure is also expected to bring benefits to the wider economy, with patients being able to return to work almost immediately after their procedure with little or no pain.

Via EPR Network
More Healthcare press releases

Pioneering Varicose Vein Treatment Gets Patients Back On Their Feet In No Time

Varicose veins can be painful and unsightly, with treatment often meaning surgery under general anaesthetic and a long recovery period.

While the traditional surgical approach has meant painful vein stripping, many UK hospitals now offer minimally invasive catheter technology that enables even severe varicose veins to be successfully treated in an outpatient setting, under a local anaesthetic.

Taking just a few minutes, a device is inserted into the diseased vein, where a catheter or fibre delivers either radio frequency or laser energy to heat and seal the vessel. The technique is extremely successful and far less painful and traumatic to the patient than vein stripping.

Endovenous laser (EVL) devices utilise an optical fibre to deliver extremely high levels of heat – over 700 degrees centigrade – that boils the blood in the vein to create a clotting effect that seals the vein as the device is withdrawn.

Radiofrequency devices operate at far lower temperatures to heat and shrink the vein walls, limiting the impact on surrounding tissues and, according to a clinical study, causing significantly less pain and bruising than laser.

Vascular surgeons using the VNUS® ClosureFAST™ catheter, the only radiofrequency device on the market today for the treatment of venous reflux, report that most patients return to normal activity almost immediately following the procedure, with little or no post-operative pain.

Radiofrequency endovenous ablation is a minimally invasive procedure for treating venous reflux disease, using Radiofrequency to heat and seal diseased veins, thereby reducing or eliminating existing varicose veins.

With the VNUS® ClosureFAST™ catheter, radiofrequency energy is delivered through a heating element seven centimetres long, to heat the collagen within the vein walls and cause the shrinkage and collapse of the vessel.

The closure procedure is generally performed using local anaesthesia, typically in a hospital theatre or an outpatient facility.

A ClosureFAST™ catheter is inserted into the vein through a tiny incision below the knee. Guided by ultrasound imaging, the vascular surgeon treats each 7cm segment of vein with a 20-second burst of radiofrequency energy, causing the vessel to shrink around the catheter.

The vascular surgeon withdraws the catheter, treating each segment until the entire vessel has been sealed. On average, 45cm of vein can be treated in three to five minutes.

In a clinical trial comparing Closure to laser, patients treated with Closure experienced less pain, less bruising and fewer complications, while a
one-year clinical data has shown the ClosureFAST™ catheter to be more than 97.4% effective in preventing reflux recurrence.

Via EPR Network
More Healthcare press releases

Revolutionary Treatment Could Mean End For Varicose Vein Surgery

A revolutionary new treatment for varicose veins is proving a successful alternative to surgery.

The VNUS ClosureFast catheter is a minimally invasive alternative treatment, which doctors claim, results in less pain and bruising than traditional vein stripping surgery.

Using the Closure system, doctors close the diseased veins by inserting the closure catheter into a vein and heating the vein wall using temperature-controlled RF energy. As it is catheter-based, it results in little to no scarring.

Heating the vein wall causes collagen in the wall to shrink and the vein to close. After the vein is sealed shut, blood then naturally reroutes to healthy veins.

Dr Thomas Proebstle, a dermatologist and expert in venous diseases, said: “Beauty treatments and aesthetic surgery is on the increase all over the world. Quite often, this is associated with risky procedures, some pain and lengthy courses of wound healing.

“With this new, less-invasive approach, the procedure is much more gentle and smoother. The risks are much lower and the pain is kept to a low level, plus it can be administered under local anesthetic.”

Dr Proebstle, who is Professor for Dermatology at University of Pecs in Hungary, added: “Obviously this type of treatment does not need to be performed in a theatre or hospital, which improves its cost-effectiveness. It can easily be performed in an outpatient setting with the right medical facilities.”

The results of a recently published three-year-study carried out at eight european centres, which involved 225 outpatients, showed a huge success rate for the treatment.

The study showed that between 12 and 24 months after the treatment, 96.4 per cent of patients reported they had no pain. After 24 months, that number had increased to more than 99 per cent.

Via EPR Network
More Healthcare press releases

Lasering Off Your Unwanted Hair

Almost all of us have unwanted hair and most of would probably like to get rid of that hair permanently. So it is not surprising that many of us look into laser hair removal in Atlanta.

There are a few things that you should know about laser hair removal before you undergo the process. A little knowledge can often make things easier and more fun. Here is a little of what you should know about laser hair removal:

  • Laser hair removal is very safe, most people will suffer no side effects or harm if the procedure is done by a cosmetic surgeon and they follow their doctors’ instructions.
  • You will have to stay out of the sun for a few days after laser hair removal because your skin will be more sensitive and susceptible to sunburn.
  • Laser hair removal is more effective for people with light skin and dark hair. It may not work as well for blondes and persons with darker skin.
  • Laser hair removal is not permanent the hair will probably grow back but will be lighter in color.
  • The process is an outpatient procedure but it has to be done in a doctor’s office.
  • You will be able to resume your normal routine after the process as long as you cover the areas of skin that were treated.
  • There can be some pain involved because the doctor will be using a laser to burn hair follicles.
  • Board certified cosmetic surgeons can offer a wide variety of procedures for the removal of unwanted hair including laser hair removal.
  • It is best to discuss the procedure with the doctor before undergoing it.
  • Laser hair removal is considered cosmetic surgery so chances are that it will not be covered by your health insurance. This means you will have to pay for the whole procedure yourself.
  • Laser hair removal is very affordable so almost anybody should be able to afford it.

Via EPR Network
More Healthcare press releases

Innovators in Health Care Meeting at HealthCamp Florida on July 30, 2011

The inaugural meeting of HealthCamp Florida will be held in Tampa, Florida on July 30, 2011. It will be held on Saturday, July 30 at Kforce in Tampa (1001 E. Palm Ave., Tampa, FL 33605). This is the inaugural event for HealthCamp Florida and the theme is ‘The remarkable innovations that are transforming healthcare.’ The focus will be on technology, policy and process areas and it is expected that these three areas will help to cross-pollinate thoughts, speakers and attendees and inform the discussions.

HealthCamps have been held in a number of other cities, including Boston, Philadelphia, San Francisco and other locations. HealthCamp will be similar to a BarCamp type of unconference but the attendees and speakers will represent a wide variety of people, industries and advocates focused around health care topics. These events have become popular because they involve interesting, high-energy people talking about interesting things.

One of the goals of HealthCamp Florida is to raise awareness of the remarkable innovators and innovations available right here in Florida. The event will bring together interesting people who might otherwise not meet at their own individual industry meetings. This will allow them to share, collaborate, learn and inspire. Some of the extraordinary innovators who are on the cutting edge of health care innovation have committed to attending the event and speaking. They will cover topics ranging from a new non-invasive medical device that provides more accurate predictions of heart risk, to iPhone and iPad apps for health care, to a neural communications device to help the brain communicate with prosthetic limbs, and to a new way to manage patient data and more. The website is www.healthcampflorida.org.

About HealthCamp Florida: HealthCamp Florida is part of the HealthCamp group of events and is designed to look at innovations in HealthCare in general and, focus on people, companies and innovations in Florida.

Via EPR Network
More Healthcare press releases

Global Health Progress Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news for the funding of neglected diseases in the developing world. In a press release issued by Policy Cures, an independent group providing research and analysis for those involved in the creation of new pharmaceuticals for neglected diseases, the group reveals that while funding for neglected diseases has increased, funding for new products has decreased.

Funders appear to be focusing more of their money toward traditional basic research. This shift has caused a $50 million drop in funding for Product Development Partnerships (PDP), non-profit organizations that partner with external organizations to drive product development for neglected diseases, including neglected tropical diseases.

Report author Dr Mary Moran, Director of Policy Cures warns funders not to “take their eyes off the ball” in the press release, stating that while the increase in funding is encouraging it is important that the funds are spent wisely.

Global Health Progress has worked with partner groups to encourage and sustain funding for the research and development of new products. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics of neglected tropical diseases in developing countries. There are no vaccines or cures for some widespread and life threatening diseases such as malaria, while existing treatments for diseases such as tuberculosis are becoming less effective due to drug resistance.

Read the full press release from Policy Cures here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/G-FINDER_Year_3_media_release.pdf,
or read the G-FINDER report on the Policy Cures website:
http://www.policycures.org/downloads/g-finder_2010.pdf.

Via EPR Network
More Healthcare press releases

Better Vision with Natural Herbs

Eyesight RX, natural eye formula developed by Dr. Ray Sahelian, M.D., is a revolutionary new vision support formula that may improve color perception, clarity of vision, day and night vision, distance vision, and the pleasure of looking at artwork, plants, nature. Eyesight Rx vision support supplies antioxidants to the tissues in the eye, including lutein, zeaxanthin, other carotenoids, and dozens of beneficial compounds that support and improve eye health.

About Advance Physician Formulas – Advance Physician Formulas, www.physicianformulas.com, provides science-based natural formulas developed by a medical doctor, top quality supplements with the highest grade raw material ingredients, along with reliable, honest, and friendly service.

About Ray Sahelian, M.D. – Dr. Sahelian has been writing about nutritional supplements for the over 20 years. His informative nutritional website, www.raysahelian.com is the highest visited site for vitamin news. Any information about vitamins typed in Google will bring up his website under the regular organic searches. Dr. Sahelian has written over 10 books about vitamins and nutritional supplements and sold over one million copies. His top two books, Mind Boosters and Natural Sex Boosters have helped thousands of people.

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Welcomes New Research on the Prevention and Treatment of Alzheimer’s

A study published in The Journal of the Federation of American Societies for Experimental Biology has suggested that the eating habits of those suffering from Alzheimer’s may have an effect on their cognitive abilities.

The research involved two groups of mice being fed two different diets over the course of 5 months. A precious study had shown that foods rich in methionine – an amino acid – were able to increase the symptoms of dementia within mice, and as a result scientists deduced that it may be effective in the increased risk of developing Alzheimer’s.

The most recent study sought then to determine if the methionine induced effects could be counteracted and even reversed. For 3 months one group of mice was fed a methionine filled diet, whilst the other group ate a healthy, balanced diet. The mice on the methionine diet were then introduced to a healthy menu, and the results were analysed after another 2 months.

The scientists found that the negative effects suffered following the 3 month period eating the amino acid had been reversed. The discovery demonstrated the capability of the brain to counteract the damaging effects it has endured. However, the study is far from conclusive, not least due to the fact that the test subjects were mice.

There is uncertainty regarding the applicability of such results to humans.

Rebecca Wood, chief executive of Alzheimer’s Research Trust commented on the findings, reminding us that:

“This research is on mice, but the Alzheimer’s Trust is supporting work looking at the effects of this type of diet on people. We look forward to the results but at the moment we don’t yet know if this type of diet could have beneficial effects for people with Alzheimer’s.”

Health insurance comparison site Quoteboffin.co.uk have given their backing to the research findings, insisting that:

“Any investigation into the causes and potential treatments for this disease are crucial, as research is the main tool we have in the battle against Alzheimer’s.”

Another piece of research carried out recently, revealed that people with larger craniums possess better cognitive abilities, including memory and thinking skills. 270 patients were recruited for the trials, the results of which were published in the Neurology journal.

Via EPR Network
More Healthcare press releases

Superior Healthplan Honors Outstanding Physicians And Practioners For 2010

Superior HealthPlan, a state leader in healthcare solutions, announced the recipients of its 2010 Summit Awards for Excellence in Care. The Summit Awards are given each year to Physicians, Practitioners and Obstetricians for providing clinical excellence. There are two award categories, one for Obstetrics and one for Primary Care.

“Superior HealthPlan believes that establishing a strong network of high caliber physicians is critical to providing quality healthcare for our members. The Summit Awards recognize the best of the best amongst our health care providers” stated Tom Wise, President and CEO of Superior HealthPlan.

The Practitioners are selected for exemplary performance in several areas, including follow up after emergency room visits and routine preventive and well care services for adults and children.

Following are the 2010 Summit Award winners (Non-OB):

– Juan Aguilera, M.D. – Hidalgo Region
– Edward Borchard, M.D. – Corpus Christi Region
– Sandra Thomas, M.D. – Burnet Region
– Luis Arandia-Antelo, M.D. – Lubbock Region
– Maria Aguirre, M.D. – San Antonio Region

“The OB category recognizes the extraordinary efforts in providing high quality obstetric care to all of our members,” explained Dr. David Harmon, Chief Medical Director. “Feedback f r o m the members and their case managers helped determine the winners.”

The individual criteria included risk-adjusted cesarean delivery rates, participation in the notification of pregnancy process and utilization of 17P, a weekly steroid injection to prevent premature birth in certain high risk women.

Following are the 2010 OB Summit Award winners:
– Jana J. Schrier, M.D.
– Andrew G. Mahaffey, M.D.
(both with the Georgetown Women’s Center)

Via EPR Network
More Healthcare press releases

HGH Supplement Review Is Now Available Online

The website gives you the HGH Article and details regarding supplements that provide a great amount of energy to the body within a very short time period. The website gives the information regarding the material content of these hormones supplements and how they are useful to the health. The Gen F20 is such a hormone supplementary that is available now on the website.

HGH Supplement Review Is Now Available Online

MR James Smith just went to the website and find the best appropriate supplementary for himself. He believed on homeopathic medicine and he found something available on the website that can suit his need. He said that the” homeopathic supplementary available on websites are having no-side effects and it can be also easily diluted with water to reduce its effect so that it can be remain less effective for a person having problem regarding heavier dose”. Just go to the website and read the contents and reviews regarding the supplementary, these reviews will tell you that how much will this medicine is good for you or will it be beneficial for you using this supplementary? The Gen F20 gives you high amount of hormones which the pituitary glands are unavailable to produce. He also added that “These supplements can be taken irrespective of the age and sex of the person consuming it”. The website will offer all the details related to these and you will get the appropriate supplementary for yourself on the website with a special discount and a review regarding it.

The reviews regarding your supplementary can be easily found out at the website. For instant if you want to have the information regarding the C9Hgh then you can just go to the website and see the reviews of these medicines. The review also contains the experience of the people who have used this medicine and the effects they have got after using this medicine. The website reviews gives you the best deal that you can get online. The online website is made more users friendly and easier so that the person can easily interact and find the appropriate thing for himself.

Via EPR Network
More Healthcare press releases

Biotivia Has Announced 15% Off Its Natural Supplement Range For US Armed Forces Personnel Serving In Afghanistan, Iraq And Korea

Biotivia has announced that it will be offering all US military personnel in Afghanistan, Iraq and Korea a 15% discount off their Resveratrol supplement range during 2010.

Biotivia Has Announced 15% Off Its Natural Supplement Range For US Armed Forces Personnel Serving In Afghanistan, Iraq And Korea

James Betz, founder and CEO of Biotivia, made this announcement to show his appreciation for the armed forces personnel who are serving abroad.

“I have served in the US Army myself and I understand the demands placed upon our armed forces. Not just to be in combat, but also to be away from friends and family in a hostile environment. All of this can have a negative effect on a person’s health, so if any of the Resveratrol enhanced natural herbal products we make can benefit serving personnel, I’m very happy to support them.”

As a former Captain in the 1st Special Forces Group, Betz knows first hand what these servicemen and women have to go through. He says, “Physical and mental well-being is high on each individual’s priorities, and Biotivia’s unique range of Resveratrol-based supplements were designed to help people from all walks of life perform at a high level.”

Betz continues: “Soldiers are strong proponents of fitness and advanced nutrition. Resveratrol and our co-ingedients helps men and women to increase physical and mental energy, improve strength and endurance, and fight aging. These are important qualities for the modern soldier.

To qualify for the discount, orders need to be dispatched to an official Armed Forces AFO or APO address. Simply insert the code ‘AFPO’ into the discount panel shown on the shopping cart at http://www.biotivia.com

A copy of the coupon is on Biotivia’s Facebook page:

http://www.facebook.com/pages/Biotivia/148780981992

A copy of the coupon is on Biotivia’s website:

http://www.biotivia.com/company/afpo.html

Via EPR Network
More Healthcare press releases

Regular Exposure To Agricultural Pesticides Might Increase The Risk Of Parkinson’s Disease

Regular exposure to agricultural pesticides might increase the risk of Parkinson’s disease (PD), according to a study published in Archives of Neurology. More exposure to pesticides means a higher chance of the neurological illness, research reports.

“While the causes of PD are still not clear,” says Kay Mixson Jenkins, author of the new children’s book Who Is Pee Dee?, “hardcore chemicals used for treating crops can’t be that good for people in any event.”

Ms. Jenkins was diagnosed with Parkinson’s when she was just thirty-four. She decided to write her book to help her children understand this devastating disease. The story follows a young boy named Colt as he tries to deal with his mother’s chronic illness.

Based on National Parkinson Foundation estimations, almost 1.5 million Americans currently have PD. It’s the second-largest neurological disorder (after Alzheimer’s) in the United States.

The illness typically develops later in life and often impairs motor skills, speech and other functions.

Many scientists and researchers believe that environmental factors can be linked to the illness:

• Aberdeen University Medical School found that people exposed to high levels of pesticides were forty-one percent more likely to develop the condition compared to people who had never been exposed; those exposed to low levels were thirteen percent more likely.

• Environmental Health News reports that the rates of Parkinson’s disease appear higher among farmers and rural residents.

• A Danish cohort study found an increased risk of Parkinson’s disease in agricultural workers.

• Emory University reported growing evidence suggesting that exposure to pesticides increases the risk of Parkinson’s disease.

• Researchers from UT Southwestern Medical Center found that people with Parkinson’s disease have significantly higher blood levels of a particular pesticide than healthy people.

“I hope studies and facts like these will help bring the government’s attention to the environmental problems our society faces today,” says Ms. Jenkins. “If we can simply protect our environment and be greener, who knows? Maybe the number of Parkinson’s cases will go down.”

In addition to writing Who Is Pee Dee?, Ms. Jenkins is a leader in a nationwide effort to raise awareness about PD. As the founder of Parkinson’s in the Park, an affiliated chapter of the National Parkinson Foundation, Ms. Jenkins has created an outreach program that encourages families and friends to participate in the treatment of PD patients.

Kay Mixson Jenkins is also the Georgia state co-coordinator for the Parkinson’s Action Network, leads the Effingham County Parkinson’s support group and was selected as a Parkinson’s patient advocate for UCB, Inc.

Who Is Pee Dee? Explaining Parkinson’s Disease to a Child by Kay Mixson Jenkins is available on Amazon.com.

Via EPR Network
More Healthcare press releases

End The Suffering From An Eating Disorder

Sunset Malibu, an elite treatment center on the California coast, has long been a transformational force in the field of rehabilitation and recovery. Now, Sunset is announcing its redoubled efforts in helping clients regain their dignity on the road to wellness.

An eating disorder is a psychologically crippling disease. By the same token, eating disorder treatment must promote psychological renewal. The most effective eating disorder treatment centers are invariably those which help clients learn to feel good about themselves again. In the end, there’s no other way to ensure the long-term success of the healing process.

Those considerations, in turn, comprise the core of Sunset Malibu’s treatment philosophy.

With its world-class caregivers and elegant accommodations, Sunset Malibu is an unparalleled recovery destination. The center has always catered to upscale clients from every corner of the globe. Now Sunset is renewing its commitment to its core values, with the goal of delivering life-changing care to individuals who seek it. At Sunset Malibu, the client always comes first.

“An eating disorder strips its victims of their self-esteem, and their sense of self-control,” said Sunset Malibu’s Program Director. “It’s our role as a eating disorder treatment center to help them recover what’s been lost, with everything from professional depression treatment to intensive life-skills training. We believe that our long record of success testifies to the soundness of our strategies.”

Sunset Malibu is a luxury treatment center for eating disorders located in Malibu, California. For further details about Sunset’s treatment strategies, accommodations, or other general facts regarding eating disorder treatment, please call 1-800-332-9202 or visit our Web site at http://www.drugrehabsunsetmalibu.com/.

Via EPR Network
More Healthcare press releases

A New Smile A New You For 2010

During 2008 and the last year the teeth whitening industry has continued to grow in the wake of the worst financial and economic downturn for many years and this is likely to be due to the fact that people are spending more money on personal grooming, botox, gym memberships and cosmetic surgery to make them look and feel better through these troubled times.

It is difficult to read any magazines or view TV makeover shows without teeth whitening being mentioned or featured and this is likely to continue as we enter 2010 as the range of teeth whitening products and services seem to give consumers the choice to suit their budgets and personal requirements.

One company who has continued to grow is White Teeth Company – (http//:www.whiteteethcompany.co.uk) who have grown their range of clinics across the south of England. Marketing Manager Jason Scott comments that the growth is due to customer demand and many of our clients are referred from previous customers.

Teeth whitening products can range from a few pounds for home whitening kits purchased in supermarkets or online to more professional services like laser teeth whitening. Technology have helped develop the industry allowing the treatment to only take just over one hour and can be undertaken in one visit.

Teeth whitening is perfect for anyone who have stained teeth caused by lifestyle staining including smoking, red wine, coffee, tea, cola, curries etc etc. Most staining on the teeth will build up over a matter of time as the enamel absorbs the colorants in our daily diets and changes the colour of our teeth.

Like any service customers are looking for the combination of competitive prices, maximum convenience and obviously the best results possible and this is going to be the challenge for the fledgling industry during 2010.

Via EPR Network
More Healthcare press releases

Lower Eye Surgery Gains Popularity with Women

The Hospital Group has reported that lower eye surgery is becoming increasingly popular amongst women. More lower eye surgery procedures were performed than upper eyelid lifts in 2009, as well as there being a larger percentage increase in the procedure over the past 5 years.

The appearance of loose droopy skin under the eyes can be very ageing and give a“sad” look to your face. Sun and smoking can accelerate the signs of ageing, while others are more prone to inherit the condition. This condition can easily be remedied with a simple eyelift procedure.

Eye bag removal is a common and simple plastic surgery procedure which can deliver dramatic results, making the eye area look more youthful, attractive and alive. The procedure is becoming increasingly popular in men as well as women. The Hospital Group can help you achieve a more bright-eyed, wide awake look.

A spokesperson for The Hospital Group, said: “THG Comment: – “We see more patients in need of eye bag removal than eye lift surgery and this procedure is a lot more popular. Eye bags can also be caused through stress, smoking and genetic factors.”

The Hospital Group is one of the UK’s leading providers of cosmetic surgery, number one in obesity surgery and tummy tuck experts. So whatever your requirements, you can rest assured in the safe hands of the professionalism and experience that THG has to offer.

Since The Hospital Group was established in 1992, it has risen to become the UK’s biggest weight loss surgery providers, performing more gastric band procedures last year than the NHS. The Hospital Group is committed to providing the very highest standards and all procedures are performed by an expert medical team in state-of-the-art facilities that are second to none.

Via EPR Network
More Healthcare press releases